Effect of serious infectious threat response initiative (SITRI) during the coronavirus disease 2019 (COVID-19) pandemic at the Veterans Affairs North Texas Health Care System.

Autor: Sopirala M; Infection Prevention and Control Program, VA North Texas Health Care System, Dallas, TX; Division of Infectious Diseases and Geographic Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX. Electronic address: msopirala@gmail.com., Hartless K; Infection Prevention and Control Program, VA North Texas Health Care System, Dallas, TX., Reid S; Infection Prevention and Control Program, VA North Texas Health Care System, Dallas, TX., Christie-Smith A; Infection Prevention and Control Program, VA North Texas Health Care System, Dallas, TX., Fiveash J; Infection Prevention and Control Program, VA North Texas Health Care System, Dallas, TX., Badejogbin A; Infection Prevention and Control Program, VA North Texas Health Care System, Dallas, TX., Omoola I; Infection Prevention and Control Program, VA North Texas Health Care System, Dallas, TX., Psenicka AO; Infection Prevention and Control Program, VA North Texas Health Care System, Dallas, TX., Jandarov R; Division of Biostatistics & Bioinformatics, Department of Environmental & Public Health Sciences, University of Cincinnati College of Medicine, Cincinnati, OH., Kazadi I; Infection Prevention and Control Program, VA North Texas Health Care System, Dallas, TX., Barriento R; Infection Prevention and Control Program, VA North Texas Health Care System, Dallas, TX.

Publikováno v: American journal of infection control [Am J Infect Control] 2023 Sep; Vol. 51 (9), pp. 980-987. Date of Electronic Publication: 2023 Apr 27.

COVID‐19, ECMO, and respiratory infection: A new triad?

Autor: Zaidi, Sara¹ (AUTHOR), Nguyen, Dang² (AUTHOR), Harky, Amer³ (AUTHOR) amer.harky@lhch.nhs.uk

Publikováno v: Journal of Cardiac Surgery. Nov2022, Vol. 37 Issue 11, p3619-3622. 4p.

A review of antibiotic synergy in carbapenemase-producing bacteria.

Autor: Vamsi, K. Sreeja¹, Moorthy, S. Rama² ram.murthy@palamurbio.com, Hemiliamma, N. Mary³, Reddy, Y. Raja Rathna³, Reddyq, B. Rama Chandra³, Deepak, J.⁴, Sravani, S.³

Publikováno v: Journal of Applied & Natural Science. 2022, Vol. 14 Issue 1, p148-162. 15p.

Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli.

Autor: Gaurav, Amit¹, Gupta, Varsha², Shrivastava, Sandeep K.³, Pathania, Ranjana¹ ranjana.pathania@bt.iitr.ac.in

Publikováno v: Communications Biology. 5/10/2021, Vol. 4 Issue 1, p1-12. 12p.

New combination approaches to combat methicillin-resistant Staphylococcus aureus (MRSA).

Autor: Sharaf, Mohamed H.¹, El-Sherbiny, Gamal M.¹ gamalelsherbiny1970@yahoo.com, Moghannem, Saad A.¹, Abdelmonem, Mohamed², Elsehemy, Islam A.³, Metwaly, Ahmed M.⁴, Kalaba, Mohamed H.¹

Publikováno v: Scientific Reports. 2/19/2021, Vol. 11 Issue 1, p1-16. 16p.